Lipid droplets are intracellular lipid-storage organelles that are thought to be derived from the endoplasmic reticulum (ER). Several pathogens, notably hepatitis C virus, use lipid droplets for replication. Numerous questions remain about how lipid droplets are generated and used by viruses. Here we show that the IFN-induced antiviral protein viperin, which localizes to the cytosolic face of the ER and inhibits HCV, localizes to lipid droplets. We show that the N-terminal amphipathic ␣-helix of viperin that is responsible for ER localization is also necessary and sufficient to localize both viperin and the fluorescent protein dsRed to lipid droplets. Point mutations in the ␣-helix that prevent ER association also disrupt lipid droplet association, and sequential deletion mutants indicate that the same number of helical turns are necessary for ER and lipid droplet association. Finally, we show that the N-terminal amphipathic ␣-helix of the hepatitis C viral protein NS5A can localize dsRed and viperin to lipid droplets. These findings indicate that the amphipathic ␣-helices of viperin and NS5A are lipid droplet-targeting domains and suggest that viperin inhibits HCV by localizing to lipid droplets using a domain and mechanism similar to that used by HCV itself.
Lipid droplets are intracellular lipid-storage organelles that are thought to be derived from the endoplasmic reticulum (ER). Several pathogens, notably hepatitis C virus, use lipid droplets for replication. Numerous questions remain about how lipid droplets are generated and used by viruses. Here we show that the IFN-induced antiviral protein viperin, which localizes to the cytosolic face of the ER and inhibits HCV, localizes to lipid droplets. We show that the N-terminal amphipathic ␣-helix of viperin that is responsible for ER localization is also necessary and sufficient to localize both viperin and the fluorescent protein dsRed to lipid droplets. Point mutations in the ␣-helix that prevent ER association also disrupt lipid droplet association, and sequential deletion mutants indicate that the same number of helical turns are necessary for ER and lipid droplet association. Finally, we show that the N-terminal amphipathic ␣-helix of the hepatitis C viral protein NS5A can localize dsRed and viperin to lipid droplets. These findings indicate that the amphipathic ␣-helices of viperin and NS5A are lipid droplet-targeting domains and suggest that viperin inhibits HCV by localizing to lipid droplets using a domain and mechanism similar to that used by HCV itself.
HCV ͉ NS5A ͉ L ipid droplets consist of a core of neutral lipids surrounded by an outer phospholipid monolayer and associated proteins. These organelles are thought to be generated when neutral lipids accumulate in the endoplasmic reticulum (ER) bilayer. The mass of lipids is believed to bulge from the ER membrane into the cytoplasm, with the cytosolic leaflet of the ER membrane forming the outer phospholipid layer of the lipid droplet (1, 2) . Recently, lipid droplets have been shown to play a role in several cellular processes, including lipid storage, lipid trafficking, and protein storage and degradation. The importance of this organelle is underscored by the fact that lipid droplets have been linked to several metabolic diseases, most notably diabetes and obesity (1) .
Lipid droplets have been shown to play a critical role in the replication of several pathogens. One of the most wellcharacterized examples is hepatitis C virus (HCV) (3, 4) . Upon infection, the HCV core initially localizes to cytosolic face of the ER. After maturation, which requires two cleavage events, the core localizes to lipid droplets by a newly exposed domain, D2, which contains two amphipathic ␣-helices (5, 6) . The core recruits the HCV nonstructural (NS) proteins and HCV replication complexes to lipid droplets (4) . Several of these NS proteins localize to the ER before lipid droplet recruitment and contain amphipathic ␣-helices that are thought to facilitate interactions with the ER (7) (8) (9) . In addition, HCV is thought to bring ER membranes in close proximity to the lipid droplet to create a localized environment with a high concentration of membranes for viral replication and assembly (4) .
Viperin is an IFN-induced antiviral protein that is induced upon HCV infection and inhibits HCV replication (10, 11) . Like the HCV NS proteins, viperin has been shown to localize to the cytosolic face of the ER through an N-terminal amphipathic ␣-helix (7, 9, 12, 13) . This N-terminal amphipathic ␣-helix is essential for viperin to inhibit HCV and influenza, as mutants lacking this domain have greatly reduced antiviral activity (11, 14) . Although the precise mechanism by which viperin inhibits HCV is still unknown, viperin was previously shown to inhibit influenza virus budding by disrupting plasma membrane lipid raft microdomains, which are sites of influenza virion assembly and budding (14) . Independent of viral infection, the N-terminal amphipathic ␣-helix of viperin inhibits protein secretion and appears to induce ER membrane curvature (12) .
In this study, we show that the N-terminal amphipathic ␣-helix is also necessary and sufficient to localize viperin to lipid droplets. Removing the N-terminal amphipathic ␣-helix prevents lipid droplet association and placing this domain at the N terminus of the reporter fluorescent protein dsRed is sufficient to relocalize dsRed from the nucleus and cytosol to lipid droplets in oleic acid-treated cells. Furthermore, mutations or truncations in the amphipathic ␣-helix that disrupt the ability of viperin to bind to the ER also prevent lipid droplet association, indicating that ER association is necessary for lipid droplet localization and that viperin is likely to be associated with lipid droplets as they form and bud from the outer leaflet of the ER membrane. In addition, we determined that the N-terminal amphipathic ␣-helix of NS5A of HCV is also necessary and sufficient to localize not only the C terminus of viperin but also dsRed to lipid droplets. These findings show that the amphipathic ␣-helices of both viperin and NS5A are lipid droplettargeting domains and suggest that viperin may use a mechanism similar to NS5A to localize to lipid droplets, allowing viperin to inhibit HCV replication.
Results

Viperin Localizes to Lipid Droplets in IFN␣-and Oleic Acid-Treated
Macrophages. Because viperin localizes to the cytoplasmic face of the ER and lipid droplets are thought to be generated from the cytosolic leaflet of the ER membrane, we examined whether viperin localizes to lipid droplets. Bone marrow-derived macrophages (BMM⌽) derived from C57/B6 wild-type mice were treated with both IFN␣ and oleic acid to induce viperin expression and lipid droplet formation, respectively. These cells were examined by immunofluorescence for colocalization with a fluorescent BODIPY dye, which stains neutral lipids within lipid droplets, and an antibody to adipocyte differentiation-related protein (ADRP), which is located in the outer phospholipid and protein layer of the lipid droplet (2) . Viperin appeared to surround the neutral lipids that were stained with BODIPY. Furthermore, viperin colocalized with ADRP, which specifically localizes to the lipid droplet delimiting monolayer (Fig. 1A) . To confirm these findings, lipid droplets were isolated using a sucrose gradient from wild-type and viperin knockout BMM⌽.
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The whole cell, membrane, and lipid droplet fractions were separated by SDS/PAGE, and viperin, GRp94, and ADRP were detected by Western blot analysis. Viperin was detected in the lipid droplet fractions of WT but not viperin knockout BMM⌽. The ER resident protein GRp94 was not detected in the lipid droplet fraction, indicating that the presence of viperin in this fraction was not due to ER contamination (Fig. 1B) .
Viperin Localizes to Naturally Occurring Lipid Droplets in Hepatocytes.
To confirm that viperin also localizes to naturally occurring lipid droplets in addition to those induced by oleic acid, a hepatocyte cell line, HepG2, was transfected with viperin and then analyzed by immunofluoresence for colocalization with BODIPY and ADRP. Consistent with the BMM⌽, viperin appeared to form a complete ring around the BODIPY-stained lipids within the lipid droplets and colocalized with ADRP located in the outer lipid droplet membrane (Fig. 1C) .
N-Terminal Amphipathic ␣-Helices of Viperin and NS5A Are Necessary and Sufficient for Lipid Droplet Association. Because previous studies have shown that viperin localizes to the cytoplasmic face of the ER via its N-terminal amphipathic ␣-helix (12), we next investigated whether this ER-targeting domain was sufficient to localize viperin to lipid droplets. 293T cells transfected with either WT viperin or viperin lacking the N-terminal amphipathic ␣-helix (⌬1-42), as diagramed in Fig. 2A , were treated with oleic acid and then examined by immunofluorescence for localization with BODIPY and ADRP. Consistent with the BMM⌽ results, WT viperin surrounded the outer rim of the BODIPY-stained lipid droplets and colocalized with ADRP (Fig. 2B) . However, when the N-terminal amphipathic ␣-helix was removed, this mutant no longer surrounded the BODIPY-stained lipids nor colocalized with ADRP (Fig. 2B ). Because HCV replicates on lipid droplets, and the NS5A protein of HCV also has an N-terminal amphipathic ␣-helix (7), we asked whether this helix was also a lipid droplet-targeting signal. A chimeric protein, in which the N-terminal amphipathic ␣-helix of viperin (1-42 amino acids) was replaced by that of NS5A (1-30 amino acids) ( Fig. 2 A) , clearly localized to the outer edge of the BODIPYstained lipids and colocalized with ADRP, indicating that the N-terminal amphipathic ␣-helix of NS5A was also sufficient to target viperin to lipid droplets (Fig. 2B) .
These results were confirmed by biochemically isolating lipid droplets with sucrose gradients and performing Western blot analyses as described above. 293T cells were transfected with either the vector control, WT viperin, viperin ⌬1-42, or the NS5A-viperin chimera, treated with oleic acid, and then examined for viperin expression in the lipid droplet fraction. Consistent with the immunofluorescence results, WT viperin and the NS5A-viperin chimera were abundant in the lipid droplet fraction, while viperin ⌬1-42 was not expressed in the lipid droplet fraction (Fig. 2C) . As shown previously, the presence of these proteins in the lipid droplet fraction was not due to abundant ER or lysosomal contamination, as evidenced by the low levels of GRp94 and TPP-1 in this fraction, respectively.
These results suggested that the amphipathic ␣-helices of viperin and NS5A are lipid-droplet-targeting domains. To determine if these amphipathic ␣-helices were both necessary and sufficient to not only target viperin but also a soluble protein to lipid droplets, we generated dsRed chimeric proteins in which the N-terminal amphipathic ␣-helix of either viperin or NS5A was fused to dsRed. By fluoresence, dsRed alone did not colocalize with BODIPY or ADRP in oleic acid-treated cells (Fig. 3A) . However, both the NS5A-dsRed and viperin-dsRed chimeric proteins localized to lipid droplet membranes, as evidenced by their colocalization with ADRP and their ring-like appearance around the BODIPY-stained droplets (Fig. 3A) . Sucrose gradient and Western blot analyses of transfected and oleic acid-treated cells confirmed these findings. Unlike dsRed, which was not detected in the lipid droplet fraction, the viperindsRed protein was abundantly present (Fig. 3B ).
Viperin Must Associate with the ER to Localize to Lipid Droplets. The mechanism by which lipid droplets are generated is still unknown. Current models propose that neutral lipids accumulate between the ER membrane leaflets and then bud into the cytoplasm, allowing the cytosolic ER membrane to surround and enclose the lipids (15) . Because viperin is located on the cytosolic face of the ER membrane, we decided to determine whether the correlation between the ability of viperin to localize to the ER BMM⌽ from wild-type B6 (WT) or viperin knock-out (KO) mice were subjected to lipid droplet fractionation using a sucrose gradient. The whole cell lysate (WC), membrane (Mem), and lipid droplet (LD) fractions were separated by SDS/ PAGE and then analyzed by Western blot analysis for viperin expression using anti-GRp94 and anti-ADRP antibodies as markers for the ER and lipid droplets, respectively. (C) HepG2 cells that had been transiently transfected with viperin were fixed, permeabilized with saponin, and then analyzed by immunofluorescence for localization to lipid droplets using BODIPY and an anti-ADRP antibody as lipid droplet markers.
and lipid droplets could be used to further examine this model. Hydrophobic residues in the N-terminal amphipathic ␣-helix of viperin, represented as a helical wheel in Fig. 4A , were mutated to glutamic acid to disrupt ER association. Several triple mutants were obtained that localized to the ER, such as W26E/L8E/L1E, in which the numbers represent the amino acid residues in the helix, with residue 9 in the protein sequence designated as residue 1 in the helix. Furthermore, other triple point mutants were obtained, notably L20E/L27E/L31E, that did not associate with the ER (Fig. 4B) . These mutants were then examined for lipid droplet association by immunofluorescence and colocal- The N-terminal amphipathic ␣-helices of viperin and NS5A are necessary and sufficient to localize dsRed to lipid droplets. 293T cells were transiently transfected with the noted dsRed constructs and then treated with 400 M oleic acid overnight to induce lipid droplet formation. (A) 293T cells were examined by immunofluoresence as described in Fig. 1 A for localization with the lipid droplet markers BODIPY and ADRP. (B) The cells were subjected to lipid droplet fractionation using a sucrose gradient. The whole cell lysate (WC), membrane (Membrane), and lipid droplet (LD) fractions were separated by SDS/PAGE and then analyzed by Western blot analysis for viperin expression. GRp94, TPP-1, and ADRP served as markers for the ER, lysosomes, and lipid droplets, respectively. Gel Lanes: vector control (1), dsRed (2), and Vip (1-42) dsRed (3).
ization with BODIPY and ADRP. Although W26E/L8E/L1E localized to lipid droplets, L20E/L27E/L31E did not costain with either BODIPY or ADRP (Fig. 4C) .
Lipid droplet fractionation and Western blot analyses confirmed these findings and showed that while W26E/L8E/L1E was abundant in lipid droplets, L20E/L27E/L31E was not present in the lipid droplet fraction (Fig. 4D) . Interestingly, these analyses also revealed that the lack of ER association subjected L20E/L27E/L31E to cleavage by an unknown cellular protease, as evidenced by its smaller size. This was not only true for this mutant but also for several other helical wheel point mutants that did not localize to the ER. To determine whether detection of L20E/L27E/L31E on lipid droplets was because of decreased protein stability, we performed radiolabeling pulse/chase analyses of WT, ⌬1-42, W26E/L8E/L1E, and L20E/L27E/L31E to examine their degradation rate. These analyses showed that, although W26E/L8E/L1E, which retained lipid droplet association, had a significantly shorter half-life, L20E/ L27E/L31E had comparable stability to WT viperin and the ⌬1-42 mutant (Fig. S1) . The reason for the accelerated degradation of W26E/L8E/L1E is unknown but may relate to instability induced by imperfect ␣-helix formation. Despite this, however, this mutant associated normally with ER membranes and lipid droplets.
To further examine the relationship between ER association and lipid droplet localization, we used a series of viperin mutants in which the eight helical turns of the N-terminal amphipathic ␣-helix were sequentially deleted. These mutants were previously examined for their ability to associate with the ER, and it was found that only four helical turns were necessary for ER Amino acid residues 9 -42 were diagramed in a helical wheel using a helical wheel projection program (http://rzlab.ucr.edu/scripts/wheel/wheel. cgi?sequence ϭ ABCDEFGHIJLKMNOP&submit ϭ Submit). The circles, diamonds, and pentagons represent hydrophilic, hydrophobic, and potentially positively charged residues, respectively. The hydrophobic and hydrophilic residues are colored in green and red, respectively, with a greater hydrophobicity or hydrophilicity corresponding to a darker, purer color. Neutral residues are represented in yellow and potentially charged residues are in blue. Residues that were mutated to glutamic acid have been outlined in black and the sequences of the amphipathic ␣-helix for wild-type viperin (WT), W26E/L8E/L1E, and L20E/L27E/L31E are shown below with the mutated residues highlighted in bold. (B) 293T cells were transiently transfected with the noted triple helical point mutants in which the noted hydrophobic residues were mutated to glutamic acid and then examined for ER localization using anti-calnexin as an ER marker. (C and D) 293T cells were transiently transfected with the noted triple helical point mutants and treated with 400 M oleic acid overnight. The cells were examined for lipid droplet localization using BODIPY and an anti-ADRP antibody as lipid droplet markers as described in Fig. 1 A (C) or by Western blot analysis of sucrose gradients as described in Fig. 2C (D) . Gel Lanes: vector control (1), wild-type viperin (2), W26E/L8E/L1E (3), and L20E/ L27E/L31E (4). (E) 293T cells were transfected with the indicated sequential helical turn deletion mutants in which one (T1), two (T1-2), three (T1-3), etc. helical turns were deleted, and then treated with 400 M oleic acid overnight. These cells were examined by immunofluorescence as described in Fig. 1 A. association (12) . Consistent with the helical wheel point mutants, we found that when a sufficient number of turns were deleted to disrupt ER association, viperin also no longer localized to lipid droplets. Specifically, mutants with deletions of one (T1), two (T1-2), three (T1-3) or four (T1-4) sequential helical turns, which were previously shown to localize to the ER, also localized to lipid droplets, as determine by immunofluorescence with BODIPY staining. Conversely, when five (T1-5), six (T1-6), seven (T1-7), or eight (T1-8) helical turns were deleted, which eliminates ER localization (12), association with lipid droplets was not observed (Fig. 4E) .
Viperin Does Not Alter the Number, Size, or Location of Lipid Droplets.
Finally, we examined whether viperin expression affected lipid droplet formation. BMM⌽ isolated from WT and viperin knockout mice were examined using BODIPY staining and flow cytometry to quantitate the lipids present in droplets. WT BMM⌽, which were derived from a CD45.2-positive C57/B6 mouse, and viperin knockout BMM⌽, which were derived from a CD45.1-positive C57/B6 mouse, were cocultured for 5 days and then treated with 400 M oleic acid overnight. The cells were harvested and stained for CD45.1, CD45.2, viperin and BODIPY. After gating on the individual CD45.1-positive and CD45.2-positive populations, the cells were examined for both viperin expression and BODIPY staining. There was no difference in the intensity of the BODIPY staining in the two populations (Fig. S2 A) . Immunofluorescence analyses of WT and viperin knockout BMM⌽ showed that there were no differences in the average number of lipid droplets per cell (Fig.  S2C ). In addition, microscopic analysis also showed that there was no difference in the size or location of the lipid droplets in WT and viperin knockout BMM⌽ (Fig. S2B) .
Discussion
Viperin is an anti-microbial protein that clearly localizes to lipid droplets. Given that several pathogens, notably HCV, are thought to induce and replicate on this intracellular organelle (1), these findings raise possibilities about how the cell responds and fights these infections. Specifically, because viperin has been shown to be induced by HCV infection and to inhibit the replication of this virus (10, 11) , the localization of viperin to lipid droplets may reflect the mechanism that viperin uses to inhibit HCV. In addition, because the N-terminal amphipathic ␣-helices of both viperin and NS5A are sufficient to target both viperin and dsRed to lipid droplets, it is clear that these helices are lipid droplet-targeting domains and that viperin and NS5A may use the same mechanism of localization. Finally, because viperin was already shown to localize to the cytoplasmic face of the ER by its N-terminal amphipathic ␣-helix, the localization of viperin to lipid droplets provides further information on how lipid droplets may be generated. Viperin has been previously shown to be highly induced upon HCV infection and to limit HCV replication by an unknown mechanism (10, 11) . In fact, when viperin was overexpressed in HCV replicon-containing cell lines, these cells showed a significant reduction in HCV RNA levels, which were comparable to the HCV RNA levels when the cells were treated with 100 U/mL IFN␣ (11) , suggesting that viperin may be one of the most important IFN-induced genes that limits HCV replication. Further analyses showed that deleting the N-terminal 50 amino acids of viperin significantly reduced the ability of viperin to limit HCV replication (11) , indicating that the N-terminal amphipathic ␣-helix that localizes viperin to both the ER and lipid droplets is necessary to limit HCV replication.
Viperin could limit HCV replication through several mechanisms. Previous studies have shown that disrupting the ability of the HCV core to localize to lipid droplets reduces the ability of HCV to produce progeny virions (16) . The fact that neither viperin overexpression nor the absence of viperin in IFN-treated cells altered lipid droplet size, shape, or formation suggests that viperin does not inhibit HCV by altering the ability of this virus to generate and induce lipid droplets for replication. However, we cannot rule out the possibility that in the context of HCV infection, viperin is able to alter either lipid droplet formation or the ability of the HCV proteins to localize to this organelle. This is a particularly interesting possibility given that previous studies suggested that viperin can alter ER membranes and apparently induce ER membrane curvature (12) . This ability to distort and curve ER membranes could also affect lipid droplet formation or morphology. Therefore, until viperin localization and function are analyzed in the context of HCV infection, these possibilities cannot be completely excluded. Furthermore, given that recent studies have shown that HCV brings ER membranes in close apposition to lipid droplets, such analyses will have to be performed carefully to distinguish ER localization from lipid droplet localization (4) .
An alternative possibility is that viperin affects the lipid content of lipid droplets. Previous studies with influenza virus indicated that viperin may alter the lipid content of cells by binding to farnesyl diphosphate synthase (FPPS), an enzyme involved in the generation of cholesterol (14) . Given that lipid droplets are lipid storage organelles that are derived from the ER where cholesterol synthesis occurs, it is possible that the ability of viperin to localize to lipid droplets provides another mechanism to alter cellular lipids. Viperin could affect the type or quantity of lipids that accumulate in the ER membrane leaflet and thus affect the lipid content of lipid droplets. Although it is still unclear if and how HCV uses the lipids within lipid droplets during its life cycle, HCV is linked with altered lipid metabolism and steatosis (3, 17) , a pathological effect that may be linked to lipid droplets.
Regardless of the means by which viperin limits HCV replication, this study shows that viperin, like NS5A, localizes to lipid droplets through its N-terminal amphipathic ␣-helix. Similar to NS5A, this domain is also responsible for the ER localization of viperin (7, 12) . Therefore, these ␣-helices are both ER-targeting and lipid droplet-targeting domains. Previous studies indicated that NS5A only minimally localizes to lipid droplets when expressed alone and that interactions with the HCV core are necessary to recruit NS5A to lipid droplets (4). However, our study examined only the N-terminal amphipathic ␣-helix of NS5A and did not examine the localization of the full-length protein. Therefore, the amphipathic ␣-helix may be sufficient to localize NS5A to lipid droplets but other domains or an altered conformation of the full-length protein in the absence of other viral components may mask or regulate this domain so that it is only exposed at certain times during infection.
Similar to our findings, other studies have identified hydrophobic domains that target proteins to lipid droplets. Some of the best characterized are the hydrophobic domains of caveolin-1 and caveolin-2, which have been shown to be necessary to target these proteins to lipid droplets (18, 19) . Although caveolins differ from viperin in that they encode two hydrophobic domains that insert into membranes and generate a cytosolic hairpin, altering hydrophobic residues within these domains prevented caveolin-1 or caveolin-2 from associating with lipid droplets (18, 19) . Furthermore, these analyses indicated that the packing of the hydrophobic residues in these domains is specifically important for localizing to lipid droplets, as altering some of these residues did not affect association with other membranes, such as the plasma membrane and Golgi (19) . Because lipid droplets are derived from ER membranes, the packing and hydrophobicity of the N-terminal amphipathic ␣-helices of viperin and NS5A may be suited for binding to both the ER and lipid droplets and may facilitate their localization to lipid droplets in the context of infection.
The fact that both viperin and the dsRed chimeric proteins appeared to completely surround the BODIPY-stained lipid droplets provides further support for the canonical model of lipid droplet generation, in which neutral lipids bud from the cytosolic leaflet of the ER membrane, which then becomes a hemi-membrane surrounding the lipid droplet (1, 2, 15) . Alternative models, such as the bicelle model, postulate that the lipids that accumulate in the ER leaflet are excised, along with both the cytosolic and luminal leaflets (1, 20) . However, with this model, viperin might be expected to localize to only part of the lipid droplet membranes, depending on both the fluidity of the membranes and whether viperin is relocalized on the lipid droplet membranes after they are formed.
Regardless of the precise model by which lipid droplets are generated, the results presented here provide further evidence that ER membranes are centrally involved in the process and indicate that the cell may have evolved strategies to localize anti-viral proteins to lipid droplets to inhibit specific pathogens. Future studies are needed to investigate how viperin inhibits these pathogens and if viperin affects lipid droplet formation or composition in the context of these infections.
Materials and Methods
Cell Lines, Antibodies, Constructs, and Reagents. 293T and HepG2 cells were maintained in Dulbecco's modified Eagle's medium with 5% bovine calf serum. Mouse anti-viperin (MaP.VIP) and rabbit anti-calnexin were described in ref. 12 . The following antibodies were purchased commercially: anti-GRp94 (Assay Designs; SPA-850), anti-TPP-1 (Abcam; ab54685), anti-ADRP (Abcam; ab52355 and Progen; 651102), and anti-dsRed (Clontech; 632496). BODIPY 493/503 and fluorescent conjugated goat anti-rabbit and goat anti-mouse secondary antibodies were purchased from Molecular Probes, and HRPconjugated secondary antibodies were purchased from Jackson Laboratories. All viperin and dsRed constructs were generated as described in ref. 12 . The NS5A construct was a kind gift from Dr. Darius Moradpour (University of Freiburg, Germany). The N-terminal amphipathic ␣-helix of NS5A was PCR amplified and then fused to the C terminus of viperin. Oleic acid was purchased from Sigma and complexed with BSA in PBS. Mouse IFN-␣ (IFN␣) was purchased from R&D Systems.
Transfection. Cells were transfected with the noted constructs using Lipofectamine 2000 (Invitrogen) following the manufacturer's instructions BMM⌽ Isolation. BMM⌽ were isolated from the hind limbs of C57/B6 wild-type and viperin knockout mice (21) and cultured in RPMI medium 1640 containing 20% FBS, L-glutamine, non-essential amino acids, sodium pyruvate, and 20 ng/mL M-CSF (R&D Systems). BMM⌽ were harvested and used after 5-7 days of culture.
Sucrose Gradients and Western Blot Analysis. Cells were treated with 400 M oleic acid overnight. On the following day, the cells were harvested, washed once with PBS, and then resuspended in cold hypotonic lysis (HLM) buffer (20 mM Tris⅐HCl and 1 mM EDTA, pH 7.4) with a protease inhibitor mixture (Roche Applied Science). Cells were Dounce homogenized on ice and the cellular debris was pelleted at 1,000 ϫ g for 10 min at 4°C. The supernatant was collected and brought to 20% sucrose using a 60% sucrose stock solution in HLM buffer. This solution was layered in the bottom of an ultracentrifuge tube, followed by a 5% sucrose solution in HLM buffer and HLM buffer alone. The gradients were centrifuged for 30 min at 13,000 rpm with no brake at 4°C. The top, lipid droplet layer and lower membrane pellet were harvested. The lipid droplet fraction was centrifuged at 14,000 ϫ g for 10 min at 4°C and the infranatant was removed with a syringe. Protein concentrations were determined using a Bradford assay and equal amounts of whole cell lysates and membrane fractions were loaded onto SDS/PAGE gels. Due to the exceedingly low protein concentration in the lipid droplet fractions, the same amount of protein in the whole cell and membrane fractions could not be used for the lipid droplet fractions; therefore, an equal amount of protein for the lipid droplet fraction was loaded for each sample. The SDS/PAGE gels were transferred to PVDF membranes (Millipore) and then probed with the indicated antibodies.
Immunofluorescence. Transfected 293T cells or primary BMM⌽ were plated onto glass coverslips and treated with 400 M oleic acid overnight. The cells were fixed in 3.7% formaldehyde, washed, and then permeabilized with 0.05% saponin. The cells were stained with the indicated antibodies or BODIPY 493/503 fluorescent dye. After washing, the cells were mounted onto slides using ProLong Gold antifade reagent (Invitrogen) and then examined under a 63ϫ objective using a Leica confocal microscope.
